The Pain That Stays When the Lesion Has Gone
Most people expect HS pain to arrive with a flare and leave when it heals. But in established cases, pain lingers between episodes — dull, deep, or burning — in areas where lesions have closed or are not visibly active. This is not incidental. It reflects what is happening internally, not just on the surface.
Understanding why HS pain persists is essential to understanding what treatment must address. Pain management alone does not interrupt the process that sustains it.
Why HS Pain Doesn't Stop When the Lesion Does
AyurvedaVedana — Vata Aggravation · Pitta InflammationEach HS episode leaves something behind. Repeated cycles of inflammation, rupture, and incomplete healing alter the local tissue environment in ways that make pain easier to trigger — and harder to resolve with each recurrence.
Sustained Background Inflammation
Even between visible flares, the internal inflammatory state that drives HS does not fully resolve. Circulating inflammatory mediators continue to sensitise local nerves and maintain a low-grade pain signal — one that intensifies sharply when a new cycle initiates, but never fully disappears in the intervening period.
Nerve Sensitisation in Affected Areas
Repeated inflammation alters the sensitivity of nerve fibres in the skin and surrounding tissue. Over time, these nerves lower their threshold for triggering pain signals — a process known as peripheral sensitisation. This is why touch, movement, or clothing contact in previously affected areas can generate pain disproportionate to any visible cause.
Structural Tissue Changes
As HS progresses, fibrotic scarring, tunnel formation, and loss of normal tissue architecture create structural pain sources that are not inflammation-dependent. Scar tissue pulling on underlying structures, pressure from partially healed tracts, and reduced tissue pliability all contribute to a persistent background ache that remains even when the active inflammatory cycle is quieter.
Central Sensitisation in Long-Standing Cases
In patients who have lived with chronic HS pain for years, the nervous system itself begins to amplify pain signals independently of peripheral tissue state. The brain's pain-processing circuits recalibrate around chronic input — which is why pain in advanced HS can feel disproportionate to what is visible, and why it does not always improve predictably when local lesions are treated.
Hormonal and Metabolic Amplification
In women with PCOS-linked or cyclical HS, hormonal fluctuations directly intensify pain perception through their effects on inflammatory pathways and tissue sensitivity. Insulin resistance and metabolic dysregulation also amplify the systemic inflammatory environment that underpins both the pain and the recurrence cycle simultaneously.
Three Patterns of Pain in HS
HS pain is not uniform. Different patients experience it differently depending on disease stage, affected location, and the degree of structural change. Recognising the pattern helps clarify what is driving it — and what treatment must target.
Acute Inflammatory Pain
Intense, throbbing pain localised to an active lesion or abscess. Arrives with the episode and is directly linked to the inflammatory process within the nodule. Pressure, heat, and movement dramatically worsen it. This is the most recognised form — but rarely the only form present in established HS.
Residual Background Pain
A dull, persistent ache in areas that have previously been affected — present even when no active lesion is visible. Often worse at night or after prolonged sitting. This form reflects the structural changes, nerve sensitisation, and sustained low-grade inflammation left behind by previous cycles rather than any single active lesion.
Neuropathic Pain
Burning, electric, or hypersensitive pain responses in affected areas — often triggered by light touch, clothing, or movement. A marker of nerve sensitisation from repeated inflammatory damage. This form does not respond well to standard pain medications and signals that the disease has altered local nerve architecture, not just tissue.
What the Pattern of Pain Is Telling You
The character of HS pain — when it arrives, how it behaves between episodes, and whether it responds to rest or persists regardless — is clinically meaningful. It maps directly onto what is happening internally.
Pain that follows a predictable pattern — worsening before menstruation, after dietary changes, or during periods of high stress — indicates active systemic drivers. Pain that is consistently present regardless of visible activity suggests structural change and sensitisation from accumulated cycles.
In either case, managing the pain signal alone does not interrupt the underlying process. The same internal environment that sustains the lesion cycle sustains the pain cycle — which is why they require the same root-cause approach, not separate symptom-by-symptom management.
"If the pain keeps returning with the lesions — or stays even when they don't — it means the internal conditions sustaining both have not been addressed."
Pain suppression only
- Reduces pain signal temporarily
- Does not alter the inflammatory environment driving it
- Does not address nerve sensitisation
- Does not prevent the next cycle — which arrives with the same or greater pain intensity
- Creates dependency on pain management as the condition progresses
Root-cause correction
- Reduces the systemic inflammatory load sustaining pain between episodes
- Interrupts the recurrence cycle that re-sensitises nerves repeatedly
- Addresses hormonal and metabolic drivers that amplify pain perception
- Allows structural tissue to stabilise and recover between episodes
- Progressive reduction in both lesion frequency and pain duration
How Pain Changes as HS Progresses
Pain is one of the clearest markers of disease progression in HS. Its character, persistence, and relationship to lesion activity all shift as the condition advances through stages — and this shift reflects cumulative internal damage, not simply more frequent episodes.
Early Stage — Episodic Pain
Pain arrives with each episode and largely resolves between them. The tissue between lesions remains relatively normal. This window — where pain is still episodic rather than persistent — represents the period when internal correction has the clearest opportunity to interrupt progression before structural damage accumulates.
Intermediate Stage — Bridging Pain
Pain begins to persist between visible episodes. Background discomfort, sensitivity in affected areas, and reduced tolerance for movement or pressure appear between flares. This pattern reflects the beginnings of nerve sensitisation and structural change — and signals that the internal inflammatory state is now sustained rather than episodic.
Advanced Stage — Continuous Pain
Pain is present continuously, varying in intensity rather than switching between present and absent. Neuropathic components — burning, hypersensitivity, electric sensations — become more prominent. Movement, work, and sleep are all affected. At this stage, addressing the pain requires both internal correction and specific attention to the sensitisation that has developed over years of repeated inflammatory cycles.
Addressing Pain Through Its Internal Source
The goal is not just to control the pain signal, but to understand why the internal environment sustaining it has not been resolved — and to address that directly, in a structured and sequential way.
Pain in HS is driven by the same internal imbalances — sustained inflammation, hormonal dysregulation, gut-driven toxin load, and immune dysregulation — that drive lesion recurrence. Reducing them in a structured sequence progressively reduces both the frequency of painful episodes and the background pain that persists between them.
Each phase of the EPOH Protocol addresses a layer of what is sustaining the inflammatory state — beginning with removing the load that keeps inflammation active, progressing through internal healing and hormonal stabilisation, and building toward the systemic resilience that prevents the cycle from re-establishing.
Lowering Inflammatory Load — Reducing the systemic toxin burden and gut-driven inflammatory input that sustains the background pain state between episodes
Internal Healing — Formulations that reduce the depth of inflammatory penetration into tissue, progressively lowering the sensitisation that keeps pain present between cycles
Functional Detox — Supporting clearance of accumulated inflammatory mediators that sustain nerve sensitisation and prolong each pain episode beyond the active lesion phase
External Care — Targeted support to the affected tissue between episodes, reducing mechanical irritation and supporting the structural integrity that limits pain from movement
Sustaining Remission — Hormonal and immune stabilisation that prevents the conditions for re-sensitisation from re-establishing as lesion frequency reduces
Understand the Full Symptom Progression
Chronic pain in HS is not an isolated symptom. It connects directly to the structural progression and the internal drivers that sustain both lesion recurrence and the pain cycle.
Persistent Pain Is a Signal the Internal Cycle Has Not Been Interrupted
When HS pain persists between episodes, or returns reliably with each flare, it reflects a sustained internal inflammatory state rather than isolated skin events. A personalised evaluation identifies which internal drivers — gut, hormonal, immune, or metabolic — are maintaining the conditions for both recurrence and pain, and maps a structured path toward interrupting them.